Fact CheckerSign in

NCT05620329Recruiting

UNC Pleural Fluid Registry

University of North Carolina Pleural Fluid Registry

Source: ClinicalTrials.gov · Last updated 21 Oct 2026

Brief summary (registry, in English)

Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to find diseases, understand how treatments work, or find new ways to treat a disease. The purpose of this study is to collect biospecimens for research from patients with known or suspected lung cancer. The information learned from the biospecimens may be used in future treatments. The purpose of this protocol is to create a pleural fluid registry for use in future studies.

Status (registry)
Recruiting
Study type
Observational
Enrollment
9999 (estimated)
First submitted
9 Nov 2022
Start date
24 Jan 2018
Primary completion date
24 Jan 2050
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Diseases
Lung cancer
NCT number
NCT05620329

What you commit to

  • Study type: Observational
  • Planned participants: 9999
  • From 24 Jan 2018 to the primary completion date, 24 Jan 2050
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • A subject will not be eligible for inclusion in this registry if, in the investigator's (or treating clinician's) opinion, the patient has any concurrent medical condition that may preclude their ability to undergo pleural fluid drainage safely.

Other

  • Incarcerated individuals

Who the study is looking for

  • Patients who are 18 years or older
  • Inpatients and outpatients
  • Diagnosed with pleural fluid, are referred for and undergo clinically indicated drainage who have clinical evidence of:
  • pulmonary infection (such as fever, leukocytosis, new or worsening infiltrate on chest x-ray, or clinical deterioration) with effusion
  • malignancy

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UNC Lingeberger Comprehensive Cancer Center
Coordinator of this site? Confirm its status
Chapel HillUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.